CD274 and neoplasm: In the early curative setting, high levels of circulating PD-L1 may represent adaptive immune resistance of the tumor against successful immune attack, resulting in increased expression and release of PD-L1 by cells in the tumor in response to pro-inflammatory cytokines secreted by infiltrating immune cells.